EIF2AK3 and infection: Infected cells showed robust PERK activation, as assessed by immunoblot analysis of whole-cell lysates harvested from cells following treatment with Tg or infection with HCoV-OC43 (Figure 6A) or SARS-CoV-2 (Figure 6C).